
Global Short Acting Contraceptives Industry Growth and Trends Forecast to 2031
Description
Summary
According to APO Research, The global Short Acting Contraceptives market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Short Acting Contraceptives is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Short Acting Contraceptives is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Short Acting Contraceptives is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global manufacturers of Short Acting Contraceptives include Bayer AG, China Resources Zizhu Pharmaceutical, Wyeth, Organon, Sichuan Chuanda Huaxi and Zhejiang Xianju, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Short Acting Contraceptives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Short Acting Contraceptives.
The Short Acting Contraceptives market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Short Acting Contraceptives market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Short Acting Contraceptives Segment by Company
Bayer AG
China Resources Zizhu Pharmaceutical
Wyeth
Organon
Sichuan Chuanda Huaxi
Zhejiang Xianju
Short Acting Contraceptives Segment by Type
21 Tablets/Box
28 Tablets/Box (With Placebo)
Short Acting Contraceptives Segment by Application
Contraception
Hormone Regulation
Others
Short Acting Contraceptives Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Short Acting Contraceptives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Short Acting Contraceptives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Short Acting Contraceptives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Short Acting Contraceptives manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Short Acting Contraceptives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
According to APO Research, The global Short Acting Contraceptives market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Short Acting Contraceptives is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Short Acting Contraceptives is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Short Acting Contraceptives is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global manufacturers of Short Acting Contraceptives include Bayer AG, China Resources Zizhu Pharmaceutical, Wyeth, Organon, Sichuan Chuanda Huaxi and Zhejiang Xianju, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Short Acting Contraceptives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Short Acting Contraceptives.
The Short Acting Contraceptives market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Short Acting Contraceptives market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Short Acting Contraceptives Segment by Company
Bayer AG
China Resources Zizhu Pharmaceutical
Wyeth
Organon
Sichuan Chuanda Huaxi
Zhejiang Xianju
Short Acting Contraceptives Segment by Type
21 Tablets/Box
28 Tablets/Box (With Placebo)
Short Acting Contraceptives Segment by Application
Contraception
Hormone Regulation
Others
Short Acting Contraceptives Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Short Acting Contraceptives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Short Acting Contraceptives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Short Acting Contraceptives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Short Acting Contraceptives manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Short Acting Contraceptives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Table of Contents
90 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Short Acting Contraceptives Market Size Estimates and Forecasts (2020-2031)
- 1.2.2 Global Short Acting Contraceptives Sales Estimates and Forecasts (2020-2031)
- 1.3 Short Acting Contraceptives Market by Type
- 1.3.1 21 Tablets/Box
- 1.3.2 28 Tablets/Box (With Placebo)
- 1.4 Global Short Acting Contraceptives Market Size by Type
- 1.4.1 Global Short Acting Contraceptives Market Size Overview by Type (2020-2031)
- 1.4.2 Global Short Acting Contraceptives Historic Market Size Review by Type (2020-2025)
- 1.4.3 Global Short Acting Contraceptives Forecasted Market Size by Type (2026-2031)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Short Acting Contraceptives Sales Breakdown by Type (2020-2025)
- 1.5.2 Europe Short Acting Contraceptives Sales Breakdown by Type (2020-2025)
- 1.5.3 Asia-Pacific Short Acting Contraceptives Sales Breakdown by Type (2020-2025)
- 1.5.4 South America Short Acting Contraceptives Sales Breakdown by Type (2020-2025)
- 1.5.5 Middle East and Africa Short Acting Contraceptives Sales Breakdown by Type (2020-2025)
- 2 Global Market Dynamics
- 2.1 Short Acting Contraceptives Industry Trends
- 2.2 Short Acting Contraceptives Industry Drivers
- 2.3 Short Acting Contraceptives Industry Opportunities and Challenges
- 2.4 Short Acting Contraceptives Industry Restraints
- 3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Short Acting Contraceptives Revenue (2020-2025)
- 3.2 Global Top Players by Short Acting Contraceptives Sales (2020-2025)
- 3.3 Global Top Players by Short Acting Contraceptives Price (2020-2025)
- 3.4 Global Short Acting Contraceptives Industry Company Ranking, 2023 VS 2024 VS 2025
- 3.5 Global Short Acting Contraceptives Major Company Production Sites & Headquarters
- 3.6 Global Short Acting Contraceptives Company, Product Type & Application
- 3.7 Global Short Acting Contraceptives Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Short Acting Contraceptives Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Short Acting Contraceptives Players Market Share by Revenue in 2024
- 3.8.3 2023 Short Acting Contraceptives Tier 1, Tier 2, and Tier 3
- 4 Short Acting Contraceptives Regional Status and Outlook
- 4.1 Global Short Acting Contraceptives Market Size and CAGR by Region: 2020 VS 2024 VS 2031
- 4.2 Global Short Acting Contraceptives Historic Market Size by Region
- 4.2.1 Global Short Acting Contraceptives Sales in Volume by Region (2020-2025)
- 4.2.2 Global Short Acting Contraceptives Sales in Value by Region (2020-2025)
- 4.2.3 Global Short Acting Contraceptives Sales (Volume & Value), Price and Gross Margin (2020-2025)
- 4.3 Global Short Acting Contraceptives Forecasted Market Size by Region
- 4.3.1 Global Short Acting Contraceptives Sales in Volume by Region (2026-2031)
- 4.3.2 Global Short Acting Contraceptives Sales in Value by Region (2026-2031)
- 4.3.3 Global Short Acting Contraceptives Sales (Volume & Value), Price and Gross Margin (2026-2031)
- 5 Short Acting Contraceptives by Application
- 5.1 Short Acting Contraceptives Market by Application
- 5.1.1 Contraception
- 5.1.2 Hormone Regulation
- 5.1.3 Others
- 5.2 Global Short Acting Contraceptives Market Size by Application
- 5.2.1 Global Short Acting Contraceptives Market Size Overview by Application (2020-2031)
- 5.2.2 Global Short Acting Contraceptives Historic Market Size Review by Application (2020-2025)
- 5.2.3 Global Short Acting Contraceptives Forecasted Market Size by Application (2026-2031)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Short Acting Contraceptives Sales Breakdown by Application (2020-2025)
- 5.3.2 Europe Short Acting Contraceptives Sales Breakdown by Application (2020-2025)
- 5.3.3 Asia-Pacific Short Acting Contraceptives Sales Breakdown by Application (2020-2025)
- 5.3.4 South America Short Acting Contraceptives Sales Breakdown by Application (2020-2025)
- 5.3.5 Middle East and Africa Short Acting Contraceptives Sales Breakdown by Application (2020-2025)
- 6 Company Profiles
- 6.1 Bayer AG
- 6.1.1 Bayer AG Comapny Information
- 6.1.2 Bayer AG Business Overview
- 6.1.3 Bayer AG Short Acting Contraceptives Sales, Revenue and Gross Margin (2020-2025)
- 6.1.4 Bayer AG Short Acting Contraceptives Product Portfolio
- 6.1.5 Bayer AG Recent Developments
- 6.2 China Resources Zizhu Pharmaceutical
- 6.2.1 China Resources Zizhu Pharmaceutical Comapny Information
- 6.2.2 China Resources Zizhu Pharmaceutical Business Overview
- 6.2.3 China Resources Zizhu Pharmaceutical Short Acting Contraceptives Sales, Revenue and Gross Margin (2020-2025)
- 6.2.4 China Resources Zizhu Pharmaceutical Short Acting Contraceptives Product Portfolio
- 6.2.5 China Resources Zizhu Pharmaceutical Recent Developments
- 6.3 Wyeth
- 6.3.1 Wyeth Comapny Information
- 6.3.2 Wyeth Business Overview
- 6.3.3 Wyeth Short Acting Contraceptives Sales, Revenue and Gross Margin (2020-2025)
- 6.3.4 Wyeth Short Acting Contraceptives Product Portfolio
- 6.3.5 Wyeth Recent Developments
- 6.4 Organon
- 6.4.1 Organon Comapny Information
- 6.4.2 Organon Business Overview
- 6.4.3 Organon Short Acting Contraceptives Sales, Revenue and Gross Margin (2020-2025)
- 6.4.4 Organon Short Acting Contraceptives Product Portfolio
- 6.4.5 Organon Recent Developments
- 6.5 Sichuan Chuanda Huaxi
- 6.5.1 Sichuan Chuanda Huaxi Comapny Information
- 6.5.2 Sichuan Chuanda Huaxi Business Overview
- 6.5.3 Sichuan Chuanda Huaxi Short Acting Contraceptives Sales, Revenue and Gross Margin (2020-2025)
- 6.5.4 Sichuan Chuanda Huaxi Short Acting Contraceptives Product Portfolio
- 6.5.5 Sichuan Chuanda Huaxi Recent Developments
- 6.6 Zhejiang Xianju
- 6.6.1 Zhejiang Xianju Comapny Information
- 6.6.2 Zhejiang Xianju Business Overview
- 6.6.3 Zhejiang Xianju Short Acting Contraceptives Sales, Revenue and Gross Margin (2020-2025)
- 6.6.4 Zhejiang Xianju Short Acting Contraceptives Product Portfolio
- 6.6.5 Zhejiang Xianju Recent Developments
- 7 North America by Country
- 7.1 North America Short Acting Contraceptives Sales by Country
- 7.1.1 North America Short Acting Contraceptives Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 7.1.2 North America Short Acting Contraceptives Sales by Country (2020-2025)
- 7.1.3 North America Short Acting Contraceptives Sales Forecast by Country (2026-2031)
- 7.2 North America Short Acting Contraceptives Market Size by Country
- 7.2.1 North America Short Acting Contraceptives Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 7.2.2 North America Short Acting Contraceptives Market Size by Country (2020-2025)
- 7.2.3 North America Short Acting Contraceptives Market Size Forecast by Country (2026-2031)
- 8 Europe by Country
- 8.1 Europe Short Acting Contraceptives Sales by Country
- 8.1.1 Europe Short Acting Contraceptives Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 8.1.2 Europe Short Acting Contraceptives Sales by Country (2020-2025)
- 8.1.3 Europe Short Acting Contraceptives Sales Forecast by Country (2026-2031)
- 8.2 Europe Short Acting Contraceptives Market Size by Country
- 8.2.1 Europe Short Acting Contraceptives Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 8.2.2 Europe Short Acting Contraceptives Market Size by Country (2020-2025)
- 8.2.3 Europe Short Acting Contraceptives Market Size Forecast by Country (2026-2031)
- 9 Asia-Pacific by Country
- 9.1 Asia-Pacific Short Acting Contraceptives Sales by Country
- 9.1.1 Asia-Pacific Short Acting Contraceptives Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 9.1.2 Asia-Pacific Short Acting Contraceptives Sales by Country (2020-2025)
- 9.1.3 Asia-Pacific Short Acting Contraceptives Sales Forecast by Country (2026-2031)
- 9.2 Asia-Pacific Short Acting Contraceptives Market Size by Country
- 9.2.1 Asia-Pacific Short Acting Contraceptives Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 9.2.2 Asia-Pacific Short Acting Contraceptives Market Size by Country (2020-2025)
- 9.2.3 Asia-Pacific Short Acting Contraceptives Market Size Forecast by Country (2026-2031)
- 10 South America by Country
- 10.1 South America Short Acting Contraceptives Sales by Country
- 10.1.1 South America Short Acting Contraceptives Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 10.1.2 South America Short Acting Contraceptives Sales by Country (2020-2025)
- 10.1.3 South America Short Acting Contraceptives Sales Forecast by Country (2026-2031)
- 10.2 South America Short Acting Contraceptives Market Size by Country
- 10.2.1 South America Short Acting Contraceptives Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 10.2.2 South America Short Acting Contraceptives Market Size by Country (2020-2025)
- 10.2.3 South America Short Acting Contraceptives Market Size Forecast by Country (2026-2031)
- 11 Middle East and Africa by Country
- 11.1 Middle East and Africa Short Acting Contraceptives Sales by Country
- 11.1.1 Middle East and Africa Short Acting Contraceptives Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 11.1.2 Middle East and Africa Short Acting Contraceptives Sales by Country (2020-2025)
- 11.1.3 Middle East and Africa Short Acting Contraceptives Sales Forecast by Country (2026-2031)
- 11.2 Middle East and Africa Short Acting Contraceptives Market Size by Country
- 11.2.1 Middle East and Africa Short Acting Contraceptives Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 11.2.2 Middle East and Africa Short Acting Contraceptives Market Size by Country (2020-2025)
- 11.2.3 Middle East and Africa Short Acting Contraceptives Market Size Forecast by Country (2026-2031)
- 12 Value Chain and Sales Channels Analysis
- 12.1 Short Acting Contraceptives Value Chain Analysis
- 12.1.1 Short Acting Contraceptives Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Short Acting Contraceptives Production Mode & Process
- 12.2 Short Acting Contraceptives Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Short Acting Contraceptives Distributors
- 12.2.3 Short Acting Contraceptives Customers
- 13 Concluding Insights
- 14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.